Matches in Wikidata for { <http://www.wikidata.org/entity/Q89376620> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q89376620 description "article scientifique publié en 2017" @default.
- Q89376620 description "artículu científicu espublizáu en febreru de 2017" @default.
- Q89376620 description "im Februar 2017 veröffentlichter wissenschaftlicher Artikel" @default.
- Q89376620 description "scientific article published on 27 February 2017" @default.
- Q89376620 description "wetenschappelijk artikel" @default.
- Q89376620 description "наукова стаття, опублікована в лютому 2017" @default.
- Q89376620 name "Symmetrical drug-related intertriginous and flexural erythema (Baboon syndrome) induced by simultaneous exposure to oral and topical terbinafine" @default.
- Q89376620 name "Symmetrical drug-related intertriginous and flexural erythema (Baboon syndrome) induced by simultaneous exposure to oral and topical terbinafine" @default.
- Q89376620 type Item @default.
- Q89376620 label "Symmetrical drug-related intertriginous and flexural erythema (Baboon syndrome) induced by simultaneous exposure to oral and topical terbinafine" @default.
- Q89376620 label "Symmetrical drug-related intertriginous and flexural erythema (Baboon syndrome) induced by simultaneous exposure to oral and topical terbinafine" @default.
- Q89376620 prefLabel "Symmetrical drug-related intertriginous and flexural erythema (Baboon syndrome) induced by simultaneous exposure to oral and topical terbinafine" @default.
- Q89376620 prefLabel "Symmetrical drug-related intertriginous and flexural erythema (Baboon syndrome) induced by simultaneous exposure to oral and topical terbinafine" @default.
- Q89376620 P1433 Q89376620-3980F44C-62E8-4E0E-B1DF-999992333D3F @default.
- Q89376620 P1476 Q89376620-41F5625A-18BD-4F6B-8457-6A321D3998CB @default.
- Q89376620 P2093 Q89376620-3C7A9A80-C8CF-4997-8CF2-5BEE63FA2687 @default.
- Q89376620 P2093 Q89376620-8094279E-17AC-4606-A5AD-0E7F20746F46 @default.
- Q89376620 P2093 Q89376620-D3E49334-BC4C-4060-BBD9-4820914FC644 @default.
- Q89376620 P2093 Q89376620-EB6A7175-6727-4E93-AECF-770D4CF3AB27 @default.
- Q89376620 P304 Q89376620-81E60B93-9FA4-4656-B9FC-7CC147710B81 @default.
- Q89376620 P31 Q89376620-1EC52F0F-3373-406A-BA1A-6D5A1849EEFA @default.
- Q89376620 P356 Q89376620-4D64B89C-E992-4A1D-B66E-92710C101C96 @default.
- Q89376620 P433 Q89376620-D8DE80C4-2016-4BB6-9B99-0CCDDEC12989 @default.
- Q89376620 P478 Q89376620-6000A2B5-42A5-4C28-9473-8D5E4C41281F @default.
- Q89376620 P577 Q89376620-EF9E15CB-7BF9-4B56-8E67-4998178BC560 @default.
- Q89376620 P698 Q89376620-085D0B08-59C9-4C55-8A9E-A73943FC832B @default.
- Q89376620 P921 Q89376620-0F665420-D9F5-4AA1-8F4A-F31DCE507F3E @default.
- Q89376620 P921 Q89376620-CEB9667D-AD91-45A6-B031-395F692C14E7 @default.
- Q89376620 P921 Q89376620-D22287A8-1CCB-4EB3-AEFF-5AD008E0FA66 @default.
- Q89376620 P356 IJD.13581 @default.
- Q89376620 P698 28244137 @default.
- Q89376620 P1433 Q15752742 @default.
- Q89376620 P1476 "Symmetrical drug-related intertriginous and flexural erythema (Baboon syndrome) induced by simultaneous exposure to oral and topical terbinafine" @default.
- Q89376620 P2093 "Kanika Sahni" @default.
- Q89376620 P2093 "Neetu Bhari" @default.
- Q89376620 P2093 "Tanvi Dev" @default.
- Q89376620 P2093 "Vinod K Sharma" @default.
- Q89376620 P304 "e168-e170" @default.
- Q89376620 P31 Q13442814 @default.
- Q89376620 P356 "10.1111/IJD.13581" @default.
- Q89376620 P433 "8" @default.
- Q89376620 P478 "56" @default.
- Q89376620 P577 "2017-02-27T00:00:00Z" @default.
- Q89376620 P698 "28244137" @default.
- Q89376620 P921 Q111795906 @default.
- Q89376620 P921 Q415259 @default.
- Q89376620 P921 Q797738 @default.